Results 181 to 190 of about 1,326,915 (353)
Stem Cell Therapy for Aging Related Diseases and Joint Diseases in Companion Animals. [PDF]
Wang Y +8 more
europepmc +1 more source
Objectives Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). The study aimed to externally validate a genetic risk score (GRS) and a combined risk score for predicting the risk of RA‐associated PF in an independent cohort of early‐RA patients. Methods This study utilized an inception cohort of 1118 patients
Mikael Brink +3 more
wiley +1 more source
Cytosolic phospholipase A2 as a therapeutic target for degenerative joint diseases. [PDF]
Huang G +6 more
europepmc +1 more source
MiR-30 Family: A Novel Avenue for Treating Bone and Joint Diseases? [PDF]
Huang J +5 more
europepmc +1 more source
Isolation of Chlamydia trachomatis from prostatic fluid in association with inflammatory joint or eye disease. [PDF]
B T Goh, P Morgan-Capner, K S Lim
openalex +1 more source
Objective We aimed to validate the Pediatric Arthritis Ultrasound Scoring System (PAUSS) for upper extremity joints in children with juvenile idiopathic arthritis (JIA). Methods Children with JIA were evaluated for elbow, wrist, or finger arthritis by clinical examination (CE) and musculoskeletal ultrasound (MSUS) with images scored according to the ...
Patricia Vega‐Fernandez +12 more
wiley +1 more source
THU0163 The association between inflammatory joint disorders and coronary heart disease: nationwide register study in 50 444 patients [PDF]
Paula Muilu +4 more
openalex +1 more source
Sex differences in medication discontinuation in axial spondyloarthritis.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or Janus kinase inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we ...
Rachael Stovall +9 more
wiley +1 more source

